Cardio-Oncology Webinar Series

Thanks to incredible recent advances in therapeutic options for cancer treatment, survival from cancer is increasing worldwide. While this increase in cancer survivorship represents an outstanding achievement, there has been increasing recognition of the toxicities of cancer therapies, in particular cardiovascular diseases that affect morbidity, mortality, and quality of life of cancer patients. Cardiovascular disease is now the leading cause of morbidity and mortality among cancer survivors.

Cardio-oncology focusses on the management of cardiovascular health in cancer patients, an emerging field with immense potential to improve cancer survivors’ quality of life. Cardio-oncology has rapidly grown to a more mature and well-established subspecialty in the last decade. Our knowledge of mechanisms and clinical manifestations of cardiotoxicity has been expanding at a rapid pace.

Throughout these webinars we will hear from experts on latest developments in this new and rapidly emerging field. The second part of our webinar series will focus on the immune checkpoint inhibitor-associated myocarditis as well as nexus between heart failure and cancer.

Part 2 Featured Speakers

Start Date 13 July 2022 | Start Time 3:00 PM AEST | Duration 75 min

Presentation Topic

Immune Checkpoint Inhibitor (ICI)-Associated Myocarditis: From Mice to Men

Prof Javid Moslehi

MD
William Grossman Distinguished Professor in Cardiology
Section Chief, Cardio-Oncology & Immunology
Associate Professor in Residence
UCSF School of Medicine
Cardiovascular Research Institute (CVRI)

Presentation Topic

Heart Failure and Cancer: Dangerous Liaisons

A/Prof Carlo Gabriele Tocchetti

MD PhD FHFA FISC
Associate Professor of Medicine
Director, Cardio-Oncology Unit
Department of Translational Medical Sciences
Center for Basic and Clinical Immunology Research (CISI)
Interdepartmental Center for Clinical and Translational Research (CIRCET)
Interdepartmental Hypertension Research Center (CIRIAPA)
University of Naples Federico II

Hosted by the Directors of the Newcastle Centre of Excellence in Cardio-Oncology:

A/Prof Aaron Sverdlov

MBBS PhD FRACP FCSANZ FESC FHFA FACC
Director of Heart Failure, University of Newcastle, Australia
Co-Director, Newcastle Centre of Excellence in Cardio-Oncology
National Heart Foundation Future Leader Fellow

A/Prof Doan Ngo

B.Pharm PhD FCSANZ FESC
Co-Director, Newcastle Centre of Excellence in Cardio-Oncology
National Heart Foundation Future Leader Fellow